Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: Optimization and ex vivo permeation

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 2385-2397

  Freag, May S ^a   Elnaggar, Yosra S R ^a   Abdallah, Ossama Y ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Flavonoids; Nanomedicine; Phosphatidylcholine complex

Indexed keywords

DIOSMIN; GLYCYRRHETINIC ACID PHOSPHOLIPID COMPLEX; NANOCARRIER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CONTENT; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; EX VIVO STUDY; FREEZE DRYING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTESTINE MUCOSA PERMEABILITY; INVESTIGATIVE PROCEDURES; MALE; NONHUMAN; PARTICLE SIZE; PHYSICAL PARAMETERS; POLYDISPERSITY INDEX; RAT; SALTING OUT; SMALL INTESTINE; SOLVENT EVAPORATION; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

FLAVONOIDS; NANOMEDICINE; PHOSPHATIDYLCHOLINE COMPLEX;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; DIMETHYL SULFOXIDE; DIOSMIN; DRUG CARRIERS; FREEZE DRYING; INTESTINAL ABSORPTION; MALE; NANOPARTICLES; PHOSPHATIDYLCHOLINES; RATS; RATS, WISTAR; SOLUBILITY;

GLYCINE MAX; RATTUS;

EID: 84879977264     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S45231     Document Type: Article

References (47)

1. Dung TD, Day CH, Binh TV, et al. PP2A mediates diosmin p53 activation to block HA22T cell proliferation and tumor growth in xenografted nude mice through PI3K-Akt-MDM2 signaling suppression. Food Chem Toxicol. 2012;50(5):1802-1810.
2. Kandaswami C, Middleton E. Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol. 1994;366:351-376.
3. Di Perri T, Auteri A. Action of S 5682 on the complement system. In vitro and in vivo study. Int Angiol. 1988;7(Suppl 2):11-15.
4. Izzo AA, Carlo GD, Mascolo N, Capasso F, Autore G. Antiulcer effect of flavonoids. Role of endogenous PAF. Phytother Res. 1994;8: 179-181.
5. Hitzenberger G. [Therapeutic effectiveness of flavonoids illustrated by daflon 500 mg.] Wien Med Wochenschr. 1997;147(18):409-412. German.
6. El-Shafae AM, El-Domiaty MM. Improved LC methods for the determination of diosmin and/or hesperidin in plant extracts and pharmaceutical formulations. J Pharm Biomed Anal. 2001;26(4):539-545.
7. Tanaka T, Makita H, Kawabata K, et al. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis. 1997;18(5): 957-965.
8. Yang M, Tanaka T, Hirose Y, Deguchi T, Mori H, Kawada Y. Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice. Int J Cancer. 1997;73(5):719-724.
9. Lonchampt M, Guardiola B, Sicot N, Bertrand M, Perdrix L, Duhault J. Protective effect of a purified flavonoid fraction against reactive oxygen radicals. In vivo and in vitro study. Arzneimittelforschung. 1989;39(8): 882-885.
10. Pari L, Srinivasan S. Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. Biomed Pharmacother. 2010;64(7):477-481.
11. Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol Ther. 2002;96(2-3):67-202.
12. Serra H, Mendes T, Bronze MR, Simplício AL. Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanones. Bioorg Med Chem. 2008;16(7):4009-4018.
13. Garner RC, Garner JV, Gregory S, Whattam M, Calam A, Leong D. Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting. J Pharm Sci. 2002;91(1):32-40.
14. Priprem A, Watanatorn J, Sutthiparinyanont S, Phachonpai W, Muchimapura S. Anxiety and cognitive effects of quercetin liposomes in rats. Nanomedicine. 2008;4(1):70-78.
15. Mukerjee A, Vishwanatha JK. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 2009;29(10):3867-3875.
16. Xiao, Zhang YH, Xu JC, Jin XH. Preparation of floating rutin-alginate-chitosan microcapsule. Chin Trad Herb Drugs. 2008;2:209-212.
17. Hou Z, Li Y, Huang Y, et al. Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery. Mol Pharm. 2013;10(1):90-101.
18. Vinod KR, Sandhya S, Chandrashekar J, et al. Review on genesis and characterization of phytosomes, Review article, IJPSRR. 2010;4:69-75.
19. Yanyu X, Yunmei S, Zhipeng C, Qineng P. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm. 2006;307(1):77-82.
20. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm. 2007;330(1-2):155-163.
21. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Enhanced therapeutic potential of naringenin-phospholipid complex in rats. J Pharm Pharmacol. 2006;58(9):1227-1233.
22. Jain S, Valvi PU, Swarnakar NK, Thanki K. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B. Mol Pharm. 2012;9(9):2542-2553.
23. Ruan LP, Chen S, Yu BY, Zhu DN, Cordell GA, Qiu SX. Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model. Eur J Med Chem. 2006;41(5):605-610.
24. Bothiraja C, Pawar AP, Dama GY, Joshi PP, Shaikh KS. Novel solvent-free gelucire extract of Plumbago zeylanica using non-everted rat intestinal sac method for improved therapeutic efficacy of plumbagin. J Pharmacol Toxicol Methods. 2012;66(1):35-42.
25. Shishu, Kamalpreet, Maheshwari M. Development and evaluation of novel microemulsion based oral formulations of 5-fluorouracil using non-everted rat intestine sac model. Drug Dev Ind Pharm. 2012;38(3):294-300.
26. European Pharmacopeia, 5th ed. 1452-1453.
27. Sweetman SC. Martindale: The Complete Drug Reference, 36th ed. London: Pharmaceutical Press; 2009.
28. Bombardelli E, Patri GF. Complex compounds of bioflavonoids wit phospholipids:their preparation and use and pharmaceutical and comsmotics compositions containing them, United states patents, patent no 5,043,323(1991).
29. Grit M, Crommelin DJ. Chemical stability of liposomes: implications for their physical stability. Chem Phys Lipids. 1993;64(1-3):3-18.
30. Teagarden DL, Baker DS. Practical aspects of lyophilization using non-aqueous co-solvent systems. Eur J Pharm Sci. 2002;15(2):115-133.
31. Elgindy N, Elkhodairy K, Molokhia A, Elzoghby A. Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide. Eur J Pharm Biopharm. 2010;74(2):397-405.
32. Salazar J, Heinzerling O, Müller RH, Möschwitzer JP. Process optimization of a novel production method for nanosuspensions using design of experiments (DoE). Int J Pharm. 2011;420(2):395-403.
33. Elsheikh MA, Elnaggar YS, Gohar EY, Abdallah OY. Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal. Int J Nanomedicine. 2012;7:3787-3802.
34. Elnaggar YS, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm. 2009;380(1-2):133-141.
35. Xu K, Liu B, Ma Y, et al. Physicochemical properties and antioxidant activities of luteolin-phospholipid complex. Molecules. 2009;14(9): 3486-3493.
36. Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58(15):1688-1713.
37. Doro PL. Development of Validation of Analytical Methodology for Determination of Content and Dissolution Evaluation [master thesis]. Catholic University of Goias, Portugal; 2009.
38. Ghazal HS, Dyas AM, Ford JL, Hutcheon GA. In vitro evaluation of the dissolution behaviour of itraconazole in bio-relevant media. Int J Pharm. 2009;366(1-2):117-123.
39. Lennernäs H, Nylander S, Ungell AL. Jejunal permeability: a comparison between the ussing chamber technique and the single-pass perfusion in humans. Pharm Res. 1997;14(5):667-671.
40. Sharma P, Chawla HP, Panchagnula R. LC determination of cephalosporins in in vitro rat intestinal sac absorption model. J Pharm Biomed Anal. 2002;27(1-2):39-50.
41. Barthe L, Bessouet M, Woodley JF, Houin G. The improved everted gut sac: a simple method to study intestinal P-glycoprtoein. Int J Pharm. 1998;173:255-258.
42. Kaul S, Ritschel WA. Studies of the intestinal transfer of coumarin and 7-hydroxycoumarin across guinea pig and rat small intestine. Arzneimittelforschung. 1981;31(5):790-795.
43. Genty M, González G, Clere C, Desangle-Gouty V, Legendre JY. Determination of the passive absorption through the rat intestine using chromatographic indices and molar volume. Eur J Pharm Sci. 2001;12(3):223-229.
44. Dixit P, Jain DK, Dumbwani J. Standardization of an ex vivo method for determination of intestinal permeability of drugs using everted rat intestine apparatus. J Pharmacol Toxicol Methods. 2012;65(1):13-17.
45. Balimane PV, Chong S, Morrison RA. Current methodologies used for evaluation of intestinal permeability and absorption. J Pharmacol Toxicol Methods. 2000;44(1):301-312.
46. Le Ferrec E, Chesne C, Artusson P, et al. In vitro models of the intestinal barrier. The report and recommendations of ECVAM Workshop 46. European Centre for the Validation of Alternative methods. Altern Lab Anim. 2001;29(6):649-668.
47. Gandia P, Lacombe O, Woodley J, Houin G. The perfused everted intestinal segment of rat. 1st communication: absorption kinetics of markers of different permeation mechanisms. Arzneimittelforschung. 2004;54(8):467-473.